New Drug Approvals at FDA See Sharp Decline

Bloomberg BNA's Jeannie Baumann joins Nancy Lyons in the Bloomberg 99.1 Washington newsroom to discuss why the FDA has approved less than half the number of new drugs this year as it has in previous years.

Nov 07, 2016

Bloomberg Podcasts